Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor.

Oncotarget - 11 Oct 2024

Arregui Marta, Calles Antonio, Galera María Del Mar, Gutiérrez Ana, López-Jiménez Carlos, Agra Carolina, Fernández Adriana, Gutiérrez Natalia, Toro María de, Álvarez Rosa

Abstract excerpt

Glomus tumors (GT) are very rare mesenchymal neoplasms arising from glomus bodies, arteriovenous structures located in the dermis and involved in thermoregulation. Although most are benign, they may occasionally present malignant histological features associated with aggressive clinical behavior, metastatic spread, and poor response to conventional chemotherapy. The BRAF V600E mutation has been identified in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carbamates

Share to BRAF gene

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Sulfonamides

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 39392364
DOI: 10.18632/oncotarget.28654
PMCID: PMC11468407

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor.PMID 39392364Read ↗

Combined treatment for a rare malignant glomus tumor of the esophagus with pulmonary and liver metastases: a case report and review of literatureSemantic proximity Read ↗

BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.Semantic proximity Read ↗

The Molecular Mechanism and Therapeutic Progress in Glomus Tumor.Semantic proximity Read ↗

Metastatic Malignant Gastric Glomus Tumour: Multidisciplinary Diagnosis & Treatment of a Rare Clinical EntitySemantic proximity Read ↗

Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential.Semantic proximity Read ↗

A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.Semantic proximity Read ↗

Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review.Semantic proximity Read ↗

Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).Semantic proximity Read ↗

BRAF and KRAS mutations in sporadic glomus tumors.Semantic proximity Read ↗

Elimination of BRAF p.V600E under selective pressure of BRAF-targeted therapy and expansion of a PIK3CA p.E542K clone in a patient with recurrent malignant glomus tumorSemantic proximity Read ↗

Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case.Semantic proximity Read ↗

[Dramatic response to encorafenib plus binimetinib in a patient with leukemoid reaction from metastatic melanoma.]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.